Amylyx Pharmaceuticals, Inc. <AMLX.O>: Leerink Partners raises target price to $40 from $28
AMLX•Related News
CrowdStrike CEO George Kurtz disposes of 20,000 common shares worth $4.37 million
CRWD•
Mercury Systems Inc <MRCY.O>: Piper Sandler raises target price to $131 from $126
MRCY•
E.L.F. Beauty, Inc. <ELF.N>: JP Morgan cuts target price to $106 from $111
ELF•
JGBs bounce back following rout that sent yields to multi-decade highs
TLT•
LG, NVIDIA deepen robotics collaboration under strategic MOU
NVDA•